<DOC>
	<DOCNO>NCT02187263</DOCNO>
	<brief_summary>This joint project Heidelberg University Greifswald University . Our objective establish unique national multi-center registry biobank well phenotyped patient non-ischemic cardiomyopathy ( CMP ) include depth clinical , molecular omics-based phenotyping serve : 1. central hub clinical outcome study . 2. joint resource diagnostic therapeutic trial . 3. common biomaterial bank . 4. resource detail molecular analysis patient ' biomaterials patient specific model system .</brief_summary>
	<brief_title>German Centre Cardiovascular Research Cardiomyopathy Register</brief_title>
	<detailed_description>The following basic research project , call module , tie rely recruitment CMP patient infrastructure provide TORCH : - Well phenotyped patient start point comprehensive next-generation genotyping , lead advanced estimate genotype-phenotype relationship clinical impact . - Functional analysis novel genomic locus relate molecular pathway base establish in-vitro ( e.g . iPS cell , yeast two hybrid ) in-vivo ( e.g . zebrafish mouse ) model system . - The integrated analysis viral load replication , inflammation , genotype clinical variable define risk variable inflammatory hereditary CMP . - By longitudinal follow-up patient , role genetic , epigenetic , metabolic , molecular biomarkers histopathology diagnosis out-come prediction define national level . The registry also facilitate investigator initiate clinical trial .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<mesh_term>Myocarditis</mesh_term>
	<mesh_term>Arrhythmogenic Right Ventricular Dysplasia</mesh_term>
	<criteria>Patients primary nonischemic cardiomyopathy include hereditary inflammatory dilate cardiomyopathy , leave ventricular noncompaction cardiomyopathy , hypertrophic cardiomyopathy , arrhythmogenic right ventricular cardiomyopathy , acute myocarditis . Preexisting cardiac disease significant valvular , ischemic pericardial disease ; Severe arterial hypertension ; Primary pulmonary artery hypertension ; Chronic advance disorder ; History treatment cardiotoxic agent chest radiation ; Drug alcohol abuse ; Patients &lt; 18 &gt; 79 year age ; Life expectancy less 1 year due noncardiac comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hereditary cardiomyopathy ,</keyword>
	<keyword>inflammatory cardiomyopathy ,</keyword>
	<keyword>registry ,</keyword>
	<keyword>biomaterial ,</keyword>
	<keyword>clinical trial</keyword>
	<keyword>Patients</keyword>
</DOC>